How Much Do GLP-1 Medications Actually Cost? A Realistic Breakdown

Let's not sugarcoat it: GLP-1 medications are expensive. If you've looked at the list price of Ozempic, Wegovy, or Mounjaro and felt your jaw drop, you're not alone. These medications can cost more than a car payment — every single month. But the list price isn't always what you'll pay. There's a complicated ecosystem of insurance, manufacturer discounts, compounding alternatives, and telehealth options that can dramatically change the actual cost. Let's break it all down.

The List Prices (What Nobody Should Actually Pay)

At full retail without any discounts or insurance:

• Wegovy (semaglutide 2.4mg): ~$1,350/month
• Zepbound (tirzepatide 15mg): ~$1,060/month
• Ozempic (semaglutide 1mg): ~$900-1,000/month
• Mounjaro (tirzepatide): ~$1,000-1,100/month
• Saxenda (liraglutide 3.0mg): ~$1,350/month
• Trulicity (dulaglutide): ~$900-1,000/month These prices are, frankly, absurd. They're what the manufacturers charge, but very few people end up paying them. Still, they set the baseline, and they're what you'll face if you're uninsured or your insurance won't cover weight-loss medications.¹

What You'll Actually Pay With Insurance

Coverage varies wildly depending on your plan, your diagnosis, and even your employer's choices. Here's the general picture: If you have type 2 diabetes: Coverage for Ozempic, Mounjaro, and Trulicity is generally good. Most commercial plans cover diabetes medications, and prior authorization is usually straightforward. You might pay anywhere from $25 to $200/month depending on your plan's drug tier and deductible. If you're using it for weight loss: This is where it gets frustrating. Many insurance plans explicitly exclude weight-loss medications. Even plans that cover them often require prior authorization, which means your doctor has to submit paperwork explaining why you need it. Employer-sponsored plans: Increasingly, large employers are adding GLP-1 coverage for weight loss — but it's far from universal. If your employer doesn't cover it, you can try advocating through HR, but there's no guarantee.

Tips for Getting Coverage

Prior authorization. Have your doctor document everything: your BMI, comorbid conditions (high blood pressure, sleep apnea, prediabetes), previous weight-loss attempts, and the medical necessity of the medication. The more thorough the documentation, the better your chances. Appeal denials. Many initial denials are overturned on appeal. Don't give up after the first "no." Your doctor can submit additional clinical evidence and peer-reviewed studies supporting the medication's use. Check for exclusions. Some plans have a specific "weight-loss medication exclusion" clause. If yours does, coverage may be impossible — but it's worth knowing upfront so you can explore other options.

Manufacturer Savings Programs

Both Novo Nordisk and Eli Lilly offer savings programs that can significantly reduce out-of-pocket costs: Novo Nordisk (Ozempic, Wegovy): Offers a savings card that can reduce copays to as low as $25/month for commercially insured patients. For uninsured patients, they have a patient assistance program based on income. Eli Lilly (Mounjaro, Zepbound): Similar savings card programs. Zepbound's savings card can bring the cost down to $25/month for eligible commercially insured patients, or $550/month for those without coverage (still expensive, but less than list price). These programs have limitations — they're typically only available for a set period (12-24 months), they don't apply to government insurance (Medicare, Medicaid), and eligibility requirements vary. But for many people, they're the difference between affording the medication and not.²

Compounding Pharmacies: The Budget Option

Compounded semaglutide and tirzepatide have become enormously popular as a more affordable alternative. These are the same active ingredients, made by compounding pharmacies rather than the brand manufacturers. Typical compounded prices:

• Compounded semaglutide: $150-400/month
• Compounded tirzepatide: $200-500/month That's a massive difference from brand-name pricing. For many people who can't get insurance coverage, compounding is the only affordable path.

The Quality Question

Here's the catch: not all compounded peptides are created equal. The FDA has flagged concerns about some compounded GLP-1 products, including:

• Products from non-sterile facilities
• Incorrect dosing
• Contamination
• Compounded versions of peptides that don't have sufficient safety data If you go the compounding route, look for:
• PCAB-accredited pharmacies — This is the gold standard for compounding quality
• 503B outsourcing facilities — Subject to FDA oversight and current Good Manufacturing Practices
• Prescriber involvement — Your doctor should be directing you to specific pharmacies they trust, not just sending you to whatever's cheapest online³

Telehealth Platforms

Several telehealth services have emerged specifically for GLP-1 prescriptions, and they can simplify the process (though not always save money): Henry Meds: Compounded semaglutide for around $300/month, including the telehealth visit and medication. Mochi Health: Various GLP-1 options, $200-400/month depending on the medication and dose. Plushcare and Push Health: Offer prescription-only services ($15-75 per visit) where you get the prescription and then fill it at your own pharmacy. The telehealth model works well for people who don't have easy access to an in-person provider or who want a streamlined experience. Just make sure the platform uses licensed providers and reputable pharmacies.

Is It Actually Worth the Money?

This is the real question, isn't it? Even at $200-400/month for compounded versions, that's $2,400-4,800 per year. Is it worth it? Consider what you're getting: clinically significant weight loss (15-22% of body weight), improvements in blood sugar, blood pressure, cardiovascular risk, and quality of life. Compare that to:

• Bariatric surgery: $15,000-25,000 upfront, plus recovery time and surgical risks
• Medical costs of untreated obesity: An estimated $1,800+/year in excess healthcare spending, not including the quality-of-life costs
• Diet programs: $200-500/month for programs with much lower success rates For many people, GLP-1 medications offer the best cost-to-outcome ratio available. But it's a personal calculation that depends on your finances, your health situation, and what alternatives you've already tried.⁴

The Bottom Line

The cost of GLP-1 medications is a real barrier, but it's not insurmountable. Start with insurance — fight for coverage if it's denied. Use manufacturer savings programs. If those don't work, reputable compounding pharmacies offer the same medications at a fraction of the cost. And if none of those options are financially viable right now? Focus on the fundamentals: nutrition, exercise, sleep, and stress management. These medications are powerful tools, but they work best alongside healthy habits — and those habits are free.

References

1. Cefalu, W.T., et al. (2018). Cardiovascular Outcomes Trials in Type 2 Diabetes. Diabetes Care, 41(8), 1627-1630. PubMed: 29967018
2. Chambers, J.D., et al. (2024). Affordability of GLP-1 Receptor Agonists. JAMA, 331(5), 387-388. PubMed: 38261521
3. FDA (2024). Compounded GLP-1 Products: FDA Concerns. FDA.gov
4. Biener, A.I., et al. (2024). Willingness to Pay for Anti-Obesity Medications. Obesity, 32(3), 512-520. PubMed: 38217345